Lai et al. indicated that chrysoeriol efficiently bound in the active site cavity, and was able to inhibit the activity of c-Met and Vascular endothelial growth factor receptor 2 (VEGFR2) and may serve as the leading compound for novel drug development, especially in the tumorigenesis of various types of cancer [88]. This evidence concerns the gene KDR and cancer.